tiprankstipranks
Trending News
More News >
Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Australian Market

Recce Pharmaceuticals Ltd. (RCE) Income Statement

Compare
20 Followers

Recce Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2025), Recce Pharmaceuticals Ltd.'s total revenue was AU$562.52K, a decrease of -87.11% from the same quarter last year. In Q4, Recce Pharmaceuticals Ltd.'s net income was AU$-13.69M. See Recce Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 7.51MAU$ 5.03MAU$ 4.37MAU$ 3.08MAU$ 1.64M
Gross Profit
AU$ -2.94MAU$ -2.19MAU$ 4.15MAU$ 2.90MAU$ 1.34M
Operating Expenses
AU$ 19.94MAU$ 21.68MAU$ 17.11MAU$ 13.96MAU$ 15.07M
Depreciation and Amortization
AU$ 71.85KAU$ 366.77KAU$ 217.16KAU$ 187.67KAU$ 295.63K
EBITDA
AU$ -20.33MAU$ -21.35MAU$ -16.99MAU$ -13.87MAU$ -14.77M
Operating Income
AU$ -22.88MAU$ -22.05MAU$ -17.33MAU$ -14.15MAU$ -15.36M
Other Income/Expenses
AU$ 1.45MAU$ -516.49KAU$ -63.06KAU$ 79.07KAU$ 285.08K
Pretax Income
AU$ -21.43MAU$ -22.57MAU$ -17.39MAU$ -14.07MAU$ -15.08M
Net Income
AU$ -21.43MAU$ -17.66MAU$ -13.08MAU$ -10.99MAU$ -13.51M
Per Share Metrics
Basic EPS
AU$ -0.09AU$ -0.10AU$ -0.07AU$ -0.06AU$ -0.09
Diluted EPS
AU$ -0.09AU$ -0.10AU$ -0.07AU$ -0.06AU$ -0.09
Weighted Average Shares Outstanding
236.98M 177.10M 175.71M 175.87M 156.95M
Weighted Average Shares Outstanding (Diluted)
236.98M 177.10M 175.71M 175.87M 156.95M
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History